Dr. Petros Nikolinakos
Claim this profileUniversity Cancer & Blood Center
Studies Prostate Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
36 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Non-Small Cell Lung Cancer
Stage III
Stage IV
L861Q positive
Affiliated Hospitals
Clinical Trials Petros Nikolinakos is currently running
ARX788
for HER2-Positive Breast Cancer
This trial tests ARX788, a new IV medicine, for patients with HER2-positive metastatic breast cancer who did not respond well to T-DXd. The medicine targets a specific protein on cancer cells to help stop their growth.
Recruiting1 award Phase 28 criteria
Mezigdomide Combo vs. Pomalidomide Combo
for Multiple Myeloma
This trial is testing two drug combinations to find out which one is better and safer for patients with multiple myeloma that has come back or not responded to previous treatments. The drugs work together to kill cancer cells by stopping their growth, helping the immune system attack them, and making it harder for them to survive.
Recruiting2 awards Phase 3
More about Petros Nikolinakos
Clinical Trial Related5 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Petros Nikolinakos has experience with
- Carboplatin
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Cisplatin
- Gemcitabine
Breakdown of trials Petros Nikolinakos has run
Prostate Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Petros Nikolinakos specialize in?
Petros Nikolinakos focuses on Prostate Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Petros Nikolinakos currently recruiting for clinical trials?
Yes, Petros Nikolinakos is currently recruiting for 5 clinical trials in Athens Georgia. If you're interested in participating, you should apply.
Are there any treatments that Petros Nikolinakos has studied deeply?
Yes, Petros Nikolinakos has studied treatments such as Carboplatin, Pembrolizumab, Nivolumab.
What is the best way to schedule an appointment with Petros Nikolinakos?
Apply for one of the trials that Petros Nikolinakos is conducting.
What is the office address of Petros Nikolinakos?
The office of Petros Nikolinakos is located at: University Cancer & Blood Center, Athens, Georgia 30607 United States. This is the address for their practice at the University Cancer & Blood Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.